Cargando…
Characterization of two new degradation products of atorvastatin calcium formed upon treatment with strong acids
Atorvastatin calcium (Lipitor(®), Sortis(®)) is a well-established cholesterol synthesis enzyme (CSE) inhibitor commonly used in the therapy of hypercholesterolemia. This drug is known to be sensitive to acid treatment, but only little data has been published on the structures of the degradation pro...
Autores principales: | Krauß, Jürgen, Klimt, Monika, Luber, Markus, Mayer, Peter, Bracher, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753681/ https://www.ncbi.nlm.nih.gov/pubmed/31579096 http://dx.doi.org/10.3762/bjoc.15.206 |
Ejemplares similares
-
Synthesis, Biological Evaluation, and Structure–Activity Relationships of 4-Aminopiperidines as Novel Antifungal Agents Targeting Ergosterol Biosynthesis
por: Krauß, Jürgen, et al.
Publicado: (2021) -
Physically Targeted Intravenous Polyurethane Nanoparticles for Controlled Release of Atorvastatin Calcium
por: Eftekhari, Behnaz Sadat, et al.
Publicado: (2017) -
Synthesis of highly substituted fluorenones via metal-free TBHP-promoted oxidative cyclization of 2-(aminomethyl)biphenyls. Application to the total synthesis of nobilone
por: Jourjine, Ilya A P, et al.
Publicado: (2021) -
Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation Products
por: Vukkum, Pallavi, et al.
Publicado: (2013) -
The calcium-free form of atorvastatin inhibits amyloid-β(1–42) aggregation in vitro
por: Nedaei, Hadi, et al.
Publicado: (2022)